|
|
|
|
|
SAN DIEGO, Feb 19, 2020 - (ACN Newswire) - DNX Biopharmaceuticals, a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of patients with life-long diseases and a resident of Johnson & Johnson Innovation - JLABS @ Shanghai, announced today that it has entered into a strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson*. Under terms of the agreement, the Lung Cancer Initiative has taken an exclusive license to research, develop and commercialize novel molecules from within the DNX portfolio. Financial terms of the collaboration were not disclosed.
"We are delighted to be collaborating with the Lung Cancer Initiative at Johnson & Johnson," said Rajiv Datar, Ph.D., co-founder and CEO of DNX. "We look forward to progressing DNX's novel molecules into clinical development."
"Our collaboration with the Lung Cancer Initiative at Johnson & Johnson was fostered by being an awardee of the Lung Cancer Innovation QuickFire Challenge and receiving residency at Johnson & Johnson Innovation - JLABS @ Shanghai," commented Dr. Carl Edwards III, CSO of DNX. "We are now looking forward to establishing our Asia-Pacific Research and Development capabilities in Shanghai, which will be wholly dedicated to Cancer Immunotherapy."
About DNX Biopharmaceuticals, Inc.
Founded in 2014 and headquartered in San Diego, California, USA, DNX is a biopharmaceutical company developing non-immunogenic, long-acting biologic therapies for the treatment of patients with life-long diseases linked to inflammation, autoinflammation and oncology. As an awardee of the Lung Cancer Innovation QuickFire Challenge, DNX received residency at Johnson & Johnson Innovation - JLABS @ Shanghai. At JLABS Shanghai, DNX will pursue an ongoing R&D effort that leverages its intrinsically disordered protein technologies designed to explore the tumor microenvironment, leading to the identification of novel pathways that can be targeted with molecules to substantially influence "anti-tumoral" therapeutic responses. Ongoing nonclinical efforts have identified several novel candidates that may act as "Immune Checkpoint Inhibitors" alone or in combination with existing standard of care anti-PD-1 and CTLA-4 therapies to reverse CD8+ T cell functions, all with the aim of improving clinical outcomes across the vast range of cancer conditions. For more information, please visit www.dnxbio.com.
*Johnson & Johnson Enterprise Innovation Inc. is the legal entity to the agreement.
Media Contact:
Claude Gingras, CFO
Claude.Gingras@dnxbio.com
Related Links
- J&J Announcement of the Winners of the Lung Cancer QuickFire Award
https://www.newsfilecorp.com/redirect/XmpnIyDP
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/52493
Topic: Press release summary
Source: DNX Biopharmaceuticals
Sectors: BioTech, Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
Latest Press Releases
Anytime Fitness Accelerates Asia-Pacific Expansion
May 12, 2026 22:56 HKT/SGT
|
|
|
Redington MD and Group CEO V.S. Hariharan Appointed to GTDC Executive Committee
May 12, 2026 21:00 HKT/SGT
|
|
|
GMG Leases New Site for Production & Office Expansion
May 12, 2026 20:29 HKT/SGT
|
|
|
CANEX and Gold Basin Resources Announce Arrangement Agreement to Facilitate CANEX'S Acquisition of Remaining Gold Basin Shares
May 12, 2026 19:30 HKT/SGT
|
|
|
SPARX Group Establishes "Mirai Creation Fund IV" Toyota Motor Corporation, Sumitomo Mitsui Banking Corporation, MUFG Bank, Ltd. and Mizuho Bank, Ltd. to Provide Capital Targeting Total Commitments of JPY100 billion 
Tuesday, May 12, 2026 6:29:00 PM
|
|
|
GTJAI Assists State Bank of Mongolia in Completing a US$100 Million Reg S Bond Tap Issuance
May 12, 2026 17:45 HKT/SGT
|
|
|
Casa Minerals Inc. Receives Proceeds of $432,777 from Warrant Exercises
May 12, 2026 17:29 HKT/SGT
|
|
|
CleverTap and Rabbit Rewards win Silver at Thailand MarTech Awards 2026 for real-time, agentic customer engagement
May 12, 2026 15:00 HKT/SGT
|
|
|
JCB and Credit Card Association of the Philippines (CCAP) Launch Partnership to Boost Financial Literacy Among Filipinos
Tuesday, May 12, 2026 1:00:00 PM
|
|
|
Gold Peak completes a HK$675 million Green and Sustainability Linked Term Loan Facility
May 12, 2026 12:21 HKT/SGT
|
|
|
|
|
More Press release >> |
|
 |
|
|
|
|
 |
|
